Iain Brunt

Following the successful exit of Aegis Veterinary Technology Ltd, I founded Mulfra.co to provide strategic and technical consulting to clients across the global animal health sector. Leveraging an international network, we support forward-thinking companies with market entry, technical innovation, and growth strategy services designed to accelerate progress and unlock value.

Established AVT to modernise rural veterinary care delivery through digital infrastructure. Led the end-to-end development and launch of ArriVet, a logistics and delivery solution built specifically for large animal veterinary practices operating in challenging field environments. Secured a significant seed equity raise and built a capable team, overseeing operations, partnerships, and commercial rollout. Under my leadership, AVT moved from concept to revenue within its first year and attracted acquisition interest from strategic investors, leading to a successful exit in January 2024 to a Canadian VC-backed acquirer.

EOS, founded by Mckinsey Alumnus Nicole Maske, is a Namibian Private Equity firm. I was primarily responsible for sourcing, modelling and presenting deals for approval at investment committee (IC) level. Euphrates agri-fund, sourcing: Sourcing and presenting deals for Namibia's first Agricultural fund. In 3 months, 3 of my deals were approved by IC. With a full value chain mandate across inputs, processing and outputs, sourcing deals which could provide synergy across the portfolio required creative thinking. Allegro fund, general growth mandate, exiting. For portfolio companies in the allegro fund, I worked with colleagues in value-add to identify and model various exit scenarios. Effects of COVID resulted in higher than expected levels of intervention from the Value-add team at the end of the lifecycle.